Medtronic plc (FRA:2M6)

Germany flag Germany · Delayed Price · Currency is EUR
83.86
-1.06 (-1.25%)
At close: Jan 9, 2026
5.10%
Market Cap107.49B
Revenue (ttm)29.88B
Net Income (ttm)4.10B
Shares Outn/a
EPS (ttm)3.17
PE Ratio26.25
Forward PE16.63
Dividend2.47 (2.94%)
Ex-Dividend DateDec 26, 2025
Volume381
Average Volume738
Open84.64
Previous Close84.92
Day's Range83.56 - 85.19
52-Week Range68.50 - 91.45
Betan/a
RSI47.77
Earnings DateFeb 17, 2026

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1949
Employees 95,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M6
Full Company Profile

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD Financial Statements

News

The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson

Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.

5 days ago - Nasdaq

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conferen...

5 days ago - PRNewsWire

2 Top Dividend Stocks to Buy for 2026

Visa has a resilient business, a solid competitive edge, and attractive avenues for growth. Medtronic is performing well, and new product launches are providing a potentially long-lasting tailwind.

9 days ago - The Motley Fool

Best Dividend Aristocrats For January 2026

The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%...

11 days ago - Seeking Alpha

MDT a Top 25 Dividend Giant With $19.23B Held By ETFs

Medtronic PLC (Symbol: MDT) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $19.23B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a...

11 days ago - Nasdaq

Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever

Bristol Myers Squibb is a pharmaceutical giant with a solid dividend history. Medtronic is a high-yield medical device maker that's nearing Dividend King status.

12 days ago - The Motley Fool

Medtronic: A Strong Contender in the Medical Device Arena

Could Medtronic be the next big opportunity in the medical device sector? Join us as we break down its strengths, challenges, and future potential in this insightful episode.

12 days ago - The Motley Fool

MDT Quantitative Stock Analysis

Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...

15 days ago - Nasdaq

Have $2,000? 3 Top Robotics Stocks to Buy and Hold for at Least a Decade

Intuitive Surgical is a first-to-market leader in the field of surgical robotics. Medtronic is making headway with its own robot-assisted surgical system.

15 days ago - The Motley Fool

Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever

This drug company offers a decent balance of risk and reward, with a 4.6% yield and a payout ratio comfortably below 100%. This medical device company has a 2.9% yield and is nearing Dividend King sta...

17 days ago - The Motley Fool

Is the Market Bullish or Bearish on Medtronic PLC?

Medtronic PLC's (NYSE: MDT) short interest as a percent of float has risen 39.62% since its last report. According to exchange reported data, there are now 18.97 million shares sold short , which is ...

17 days ago - Benzinga

Ex-Dividend Reminder: Medtronic, Danaher and DENTSPLY SIRONA

Looking at the universe of stocks we cover at Dividend Channel, on 12/26/25, Medtronic PLC (Symbol: MDT), Danaher Corp (Symbol: DHR), and DENTSPLY SIRONA Inc (Symbol: XRAY) will all trade ex-dividend ...

18 days ago - Nasdaq

FDA Flags Medtronic Heart Catheter Recall As Most Serious Safety Risk

The U.S. Food and Drug Administration (FDA) said it is aware that Medtronic Plc (NYSE: MDT) has notified customers to remove certain Left Heart Vent Catheters from use and sale, citing safety concern...

18 days ago - Benzinga

The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences

Cardinal Health leads Zacks' list of large-cap MedTech stocks as AI adoption, robotics and rising procedure volumes set up continued gains in 2026.

19 days ago - Nasdaq

Medtronic a Top Ranked SAFE Dividend Stock With 2.9% Yield (MDT)

Medtronic PLC (Symbol: MDT) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.9% yield, as well as a s...

19 days ago - Nasdaq

3 Top Dividend Stocks I Plan to Buy Hand Over Fist in 2026

Brookfield Renewable aims to increase its dividend by 5% to 9% each year. Realty Income has hiked its dividend for 113 consecutive quarters.

21 days ago - The Motley Fool

Medtronic: A Defensive Gem For Uncertain Times

Medtronic (MDT) is a strong defensive investment with stable growth, 49 years of dividend increases, and fair value. Read here for more analysis.

22 days ago - Seeking Alpha

Medtronic's Diabetes Unit MiniMed Files For US IPO

Medtronic ‘s (NYSE: MDT) diabetes unit, MiniMed Group, filed for a U.S. initial public offering (IPO) on Friday, as part of its separation from the medical devices maker. The Northridge, California-b...

22 days ago - Benzinga

Medtronic's Diabetes Unit MiniMed Files For IPO On Nasdaq

(RTTNews) - Medtronic plc (MDT) announced that its Diabetes division—set to operate under the name MiniMed—has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commissi...

22 days ago - Nasdaq

Medtronic (MDT) Plans IPO for MiniMed Diabetes Business

Medtronic (MDT) Plans IPO for MiniMed Diabetes Business

22 days ago - GuruFocus

Medtronic Spin-Off MiniMed Files for IPO

22 days ago - The Wall Street Journal

Medtronic (MDT) Plans MiniMed IPO to Boost Diabetes Business

Medtronic (MDT) Plans MiniMed IPO to Boost Diabetes Business

22 days ago - GuruFocus

Medtronic plc: Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will o...

22 days ago - Finanz Nachrichten

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland , Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will oper...

22 days ago - PRNewsWire